Technical Analysis for CYTH - Cyclo Therapeutics, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | Down | Down |
| Historical CYTH trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Wide Bands | Range Expansion | 4.26% | |
| Down 3 Days in a Row | Weakness | 4.26% | |
| Down 4 Days in a Row | Weakness | 4.26% | |
| Down 5 Days in a Row | Weakness | 4.26% | |
| Oversold Stochastic | Weakness | 4.26% | |
| Narrow Range Bar | Range Contraction | -3.14% | |
| Wide Bands | Range Expansion | -3.14% | |
| Down 3 Days in a Row | Weakness | -3.14% | |
| Down 4 Days in a Row | Weakness | -3.14% | |
| Down 5 Days in a Row | Weakness | -3.14% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | about 3 hours ago |
| Up 3% | about 5 hours ago |
| Up 2% | about 5 hours ago |
| Up 1% | about 5 hours ago |
| Down 5% | 1 day ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: ???
Cyclo Therapeutics, Inc. is a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of Niemann-Pick Disease Type C and Alzheimer’s Disease. The company’s Trappsol® Cyclo™, an orphan drug designated product in the United States and Europe, is the subject of three ongoing formal clinical trials for Niemann-Pick Disease Type C, a rare and fatal genetic disease. The company is planning an early phase clinical trial using Trappsol Cyclo intravenously in Alzheimer’s Disease based on encouraging data from an Expanded Access program for late-onset Alzheimer’s Disease. Additional indications for the active ingredient in Trappsol Cyclo are in development.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Clinical Medicine Rare Diseases Alzheimer's Disease Lipid Storage Disorders
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Clinical Medicine Rare Diseases Alzheimer's Disease Lipid Storage Disorders
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 17.75 |
| 52 Week Low | 3.55 |
| Average Volume | 949,173 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 9.29 |
| 20-Day Moving Average | 9.43 |
| 10-Day Moving Average | 7.90 |
| Average True Range | 1.21 |
| ADX | 21.9 |
| +DI | 21.29 |
| -DI | 28.37 |
| Chandelier Exit (Long, 3 ATRs ) | 11.25 |
| Chandelier Exit (Short, 3 ATRs ) | 9.89 |
| Upper Bollinger Band | 13.21 |
| Lower Bollinger Band | 5.65 |
| Percent B (%b) | 0.15 |
| BandWidth | 80.24 |
| MACD Line | -0.54 |
| MACD Signal Line | -0.22 |
| MACD Histogram | -0.3205 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 8.39 | ||||
| Resistance 3 (R3) | 8.39 | 7.85 | 8.13 | ||
| Resistance 2 (R2) | 7.85 | 7.45 | 7.86 | 8.04 | |
| Resistance 1 (R1) | 7.33 | 7.20 | 7.06 | 7.33 | 7.95 |
| Pivot Point | 6.79 | 6.79 | 6.66 | 6.80 | 6.79 |
| Support 1 (S1) | 6.27 | 6.39 | 6.00 | 6.27 | 5.65 |
| Support 2 (S2) | 5.73 | 6.14 | 5.74 | 5.56 | |
| Support 3 (S3) | 5.21 | 5.73 | 5.48 | ||
| Support 4 (S4) | 5.21 |
